ARTICLE | Clinical News
Combo Bio-engineered Sirolimus Eluting Stent: Pivotal trial data
April 29, 2013 7:00 AM UTC
The open-label, Australian pivotal REMEDEE trial in 183 patients with de novo native coronary artery stenosis showed that OrbusNeich's Combo Bio-engineered Sirolimus Eluting stent met the primary endp...